Filaggrin null mutations associate with increased frequencies of allergen-specific CD4+ T-helper 2 cells in patients with atopic eczema.

BACKGROUND: Filaggrin null mutations associate with atopic eczema and also with asthma when present with eczema. However, while epidermal dysfunction is an important factor in disease pathogenesis, it is unclear how such dysfunction interacts with immune responses to contribute to cutaneous and othe...

Full description

Bibliographic Details
Main Authors: Mcpherson, T, Sherman, V, Aslam, A, Crack, L, Chan, H, Lloyd-Lavery, A, Jones, L, Ardern-Jones, M, Ogg, G
Format: Journal article
Language:English
Published: 2010
_version_ 1826303401424584704
author Mcpherson, T
Sherman, V
Aslam, A
Crack, L
Chan, H
Lloyd-Lavery, A
Jones, L
Ardern-Jones, M
Ogg, G
author_facet Mcpherson, T
Sherman, V
Aslam, A
Crack, L
Chan, H
Lloyd-Lavery, A
Jones, L
Ardern-Jones, M
Ogg, G
author_sort Mcpherson, T
collection OXFORD
description BACKGROUND: Filaggrin null mutations associate with atopic eczema and also with asthma when present with eczema. However, while epidermal dysfunction is an important factor in disease pathogenesis, it is unclear how such dysfunction interacts with immune responses to contribute to cutaneous and other inflammatory atopic disease. OBJECTIVES: To gain a better understanding of the mechanisms underlying such predisposition in order to understand different disease phenotypes and possibly identify potential treatment targets. METHODS: We studied 33 individuals with atopic eczema and used interleukin-4 immunospot and human leucocyte antigen class II tetrameric complexes to investigate the peripheral blood allergen-specific CD4+ T-cell responses. RESULTS: Filaggrin null mutations associated with significantly (P<0·05) higher frequencies of allergen-specific CD4+ T-helper 2 cell responses. CONCLUSIONS: These data would support a model where barrier dysfunction possibly promotes greater allergen penetration and delivery to drive allergen-specific CD4+ T cells. This could further contribute to respiratory and cutaneous inflammatory disease.
first_indexed 2024-03-07T06:02:07Z
format Journal article
id oxford-uuid:ec90246f-484e-4cee-a3bd-4ad81f615e68
institution University of Oxford
language English
last_indexed 2024-03-07T06:02:07Z
publishDate 2010
record_format dspace
spelling oxford-uuid:ec90246f-484e-4cee-a3bd-4ad81f615e682022-03-27T11:18:25ZFilaggrin null mutations associate with increased frequencies of allergen-specific CD4+ T-helper 2 cells in patients with atopic eczema.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:ec90246f-484e-4cee-a3bd-4ad81f615e68EnglishSymplectic Elements at Oxford2010Mcpherson, TSherman, VAslam, ACrack, LChan, HLloyd-Lavery, AJones, LArdern-Jones, MOgg, GBACKGROUND: Filaggrin null mutations associate with atopic eczema and also with asthma when present with eczema. However, while epidermal dysfunction is an important factor in disease pathogenesis, it is unclear how such dysfunction interacts with immune responses to contribute to cutaneous and other inflammatory atopic disease. OBJECTIVES: To gain a better understanding of the mechanisms underlying such predisposition in order to understand different disease phenotypes and possibly identify potential treatment targets. METHODS: We studied 33 individuals with atopic eczema and used interleukin-4 immunospot and human leucocyte antigen class II tetrameric complexes to investigate the peripheral blood allergen-specific CD4+ T-cell responses. RESULTS: Filaggrin null mutations associated with significantly (P<0·05) higher frequencies of allergen-specific CD4+ T-helper 2 cell responses. CONCLUSIONS: These data would support a model where barrier dysfunction possibly promotes greater allergen penetration and delivery to drive allergen-specific CD4+ T cells. This could further contribute to respiratory and cutaneous inflammatory disease.
spellingShingle Mcpherson, T
Sherman, V
Aslam, A
Crack, L
Chan, H
Lloyd-Lavery, A
Jones, L
Ardern-Jones, M
Ogg, G
Filaggrin null mutations associate with increased frequencies of allergen-specific CD4+ T-helper 2 cells in patients with atopic eczema.
title Filaggrin null mutations associate with increased frequencies of allergen-specific CD4+ T-helper 2 cells in patients with atopic eczema.
title_full Filaggrin null mutations associate with increased frequencies of allergen-specific CD4+ T-helper 2 cells in patients with atopic eczema.
title_fullStr Filaggrin null mutations associate with increased frequencies of allergen-specific CD4+ T-helper 2 cells in patients with atopic eczema.
title_full_unstemmed Filaggrin null mutations associate with increased frequencies of allergen-specific CD4+ T-helper 2 cells in patients with atopic eczema.
title_short Filaggrin null mutations associate with increased frequencies of allergen-specific CD4+ T-helper 2 cells in patients with atopic eczema.
title_sort filaggrin null mutations associate with increased frequencies of allergen specific cd4 t helper 2 cells in patients with atopic eczema
work_keys_str_mv AT mcphersont filaggrinnullmutationsassociatewithincreasedfrequenciesofallergenspecificcd4thelper2cellsinpatientswithatopiceczema
AT shermanv filaggrinnullmutationsassociatewithincreasedfrequenciesofallergenspecificcd4thelper2cellsinpatientswithatopiceczema
AT aslama filaggrinnullmutationsassociatewithincreasedfrequenciesofallergenspecificcd4thelper2cellsinpatientswithatopiceczema
AT crackl filaggrinnullmutationsassociatewithincreasedfrequenciesofallergenspecificcd4thelper2cellsinpatientswithatopiceczema
AT chanh filaggrinnullmutationsassociatewithincreasedfrequenciesofallergenspecificcd4thelper2cellsinpatientswithatopiceczema
AT lloydlaverya filaggrinnullmutationsassociatewithincreasedfrequenciesofallergenspecificcd4thelper2cellsinpatientswithatopiceczema
AT jonesl filaggrinnullmutationsassociatewithincreasedfrequenciesofallergenspecificcd4thelper2cellsinpatientswithatopiceczema
AT ardernjonesm filaggrinnullmutationsassociatewithincreasedfrequenciesofallergenspecificcd4thelper2cellsinpatientswithatopiceczema
AT oggg filaggrinnullmutationsassociatewithincreasedfrequenciesofallergenspecificcd4thelper2cellsinpatientswithatopiceczema